Consensus guidelines for the detection of immunogenic cell death.
Oncoimmunology
; 3(9): e955691, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-25941621
APC, antigen-presenting cell; ATF6, activating transcription factor 6; ATP release; BAK1, BCL2-antagonist/killer 1; BAX, BCL2-associated X protein; BCL2, B-cell CLL/lymphoma 2 protein; CALR, calreticulin; CTL, cytotoxic T lymphocyte; DAMP, damage-associated molecular pattern; DAPI, 4',6-diamidino-2-phenylindole; DiOC6(3), 3,3'-dihexyloxacarbocyanine iodide; EIF2A, eukaryotic translation initiation factor 2A; ER, endoplasmic reticulum; FLT3LG, fms-related tyrosine kinase 3 ligand; G3BP1, GTPase activating protein (SH3 domain) binding protein 1; GFP, green fluorescent protein; H2B, histone 2B; HMGB1; HMGB1, high mobility group box 1; HSP, heat shock protein; HSV-1, herpes simplex virus type I; ICD, immunogenic cell death; IFN, interferon; IL, interleukin; MOMP, mitochondrial outer membrane permeabilization; PDIA3, protein disulfide isomerase family A; PI, propidium iodide; RFP, red fluorescent protein; TLR, Toll-like receptor; XBP1, X-box binding protein 1; autophagy; calreticulin; endoplasmic reticulum stress; immunotherapy; member 3; Δψm, mitochondrial transmembrane potential
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Language:
En
Journal:
Oncoimmunology
Year:
2014
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos